Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Aug;88(2):614–622. doi: 10.1172/JCI115346

The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.

R G Douglas 1, P D Gluckman 1, K Ball 1, B Breier 1, J H Shaw 1
PMCID: PMC295398  PMID: 1864971

Abstract

In vivo effects of 300-min infusions of recombinant insulinlike growth factor I (IGF-I) and IGF-II on glucose and protein metabolism have been investigated in awake, fasted lambs. Two doses of recombinant human (rh) IGF-I were infused: 6.7 nmol/kg.h, which induced hypoglycemia, and 2.0 nmol/kg.h, which did not. The effects were compared with an insulin infusion (0.17 nmol/kg.h) that had the same hypoglycemic potential as the high dose rhIGF-I infusion. rhIGF-II was infused at a rate of 6.7 nmol/kg.h. Primed constant infusions of isotopically labeled glucose, urea and leucine tracers were used to determine glucose and protein kinetics. rhIGF-I lowered blood glucose by increasing the rate of glucose clearance (P less than 0.01), in contrast to insulin, which both increased clearance and reduced glucose production. Net protein loss was reduced after infusion of low and high dose rhIGF-I and insulin by 11% (P less than 0.05), 15% (P less than 0.01), and 12% (P less than 0.05), respectively. rhIGF-II infusion did not alter the rate of net protein loss. In contrast to insulin, high dose rhIGF-I infusion increased the rate of protein synthesis in skeletal (P less than 0.05) and cardiac muscle (P less than 0.01) and in hepatic tissue (P less than 0.05). We conclude that (a) protein metabolism is more sensitive than glucose metabolism to rhIGF-I infusion, as protein loss was reduced by an rhIGF-I infusion that did not alter glucose kinetics; (b) protein synthesis is increased by rhIGF-I infusion but not by insulin infusion; and (c) rhIGF-II is a less effective anabolic agent than rhIGF-I. We speculate that the effects of rhIGF-I on protein metabolism are not mediated by insulin receptors.

Full text

PDF
614

Images in this article

619Image
on p.619
619Image
on p.619
619Image
on p.619
619Image
on p.619
619Image
on p.619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar R. S., Clemmons D. R., Boes M., Busby W. H., Booth B. A., Dake B. L., Sandra A. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology. 1990 Sep;127(3):1078–1086. doi: 10.1210/endo-127-3-1078. [DOI] [PubMed] [Google Scholar]
  2. Barreca A., Minuto F. Somatomedins: chemical and functional characteristics of the different molecular forms. J Endocrinol Invest. 1989 Apr;12(4):279–293. doi: 10.1007/BF03349988. [DOI] [PubMed] [Google Scholar]
  3. Bassett N. S., Breier B. H., Hodgkinson S. C., Davis S. R., Henderson H. V., Gluckman P. D. Plasma clearance of radiolabelled IGF-1 in the late gestation ovine fetus. J Dev Physiol. 1990 Aug;14(2):73–79. [PubMed] [Google Scholar]
  4. Blum W. F., Jenne E. W., Reppin F., Kietzmann K., Ranke M. B., Bierich J. R. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology. 1989 Aug;125(2):766–772. doi: 10.1210/endo-125-2-766. [DOI] [PubMed] [Google Scholar]
  5. Blundell T. L., Bedarkar S., Rinderknecht E., Humbel R. E. Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding. Proc Natl Acad Sci U S A. 1978 Jan;75(1):180–184. doi: 10.1073/pnas.75.1.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bolinder J., Lindblad A., Engfeldt P., Arner P. Studies of acute effects of insulin-like growth factors I and II in human fat cells. J Clin Endocrinol Metab. 1987 Oct;65(4):732–737. doi: 10.1210/jcem-65-4-732. [DOI] [PubMed] [Google Scholar]
  7. Breier B. H., Gallaher B. W., Gluckman P. D. Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Endocrinol. 1991 Mar;128(3):347–357. doi: 10.1677/joe.0.1280347. [DOI] [PubMed] [Google Scholar]
  8. Butler J. H., Gluckman P. D. Circulating insulin-like growth factor-binding proteins in fetal, neonatal and adult sheep. J Endocrinol. 1986 Jun;109(3):333–338. doi: 10.1677/joe.0.1090333. [DOI] [PubMed] [Google Scholar]
  9. Caro J. F., Poulos J., Ittoop O., Pories W. J., Flickinger E. G., Sinha M. K. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest. 1988 Apr;81(4):976–981. doi: 10.1172/JCI113451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dahn M. S., Lange M. P., Jacobs L. A. Insulinlike growth factor 1 production is inhibited in human sepsis. Arch Surg. 1988 Nov;123(11):1409–1414. doi: 10.1001/archsurg.1988.01400350123019. [DOI] [PubMed] [Google Scholar]
  11. Daughaday W. H., Ward A. P., Goldberg A. C., Trivedi B., Kapadia M. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. J Clin Endocrinol Metab. 1982 Nov;55(5):916–921. doi: 10.1210/jcem-55-5-916. [DOI] [PubMed] [Google Scholar]
  12. Davenport M. L., Clemmons D. R., Miles M. V., Camacho-Hubner C., D'Ercole A. J., Underwood L. E. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology. 1990 Sep;127(3):1278–1286. doi: 10.1210/endo-127-3-1278. [DOI] [PubMed] [Google Scholar]
  13. Davis S. R., Barry T. N., Hughson G. A. Protein synthesis in tissues of growing lambs. Br J Nutr. 1981 Nov;46(3):409–419. doi: 10.1079/bjn19810049. [DOI] [PubMed] [Google Scholar]
  14. Davis S. R., Gluckman P. D., Hodgkinson S. C., Farr V. C., Breier B. H., Burleigh B. D. Comparison of the effects of administration of recombinant bovine growth hormone or N-Met insulin-like growth factor-I to lactating goats. J Endocrinol. 1989 Oct;123(1):33–39. doi: 10.1677/joe.0.1230033. [DOI] [PubMed] [Google Scholar]
  15. Douglas R. G., Humberstone D. A., Haystead A., Shaw J. H. Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. Br J Surg. 1990 Jul;77(7):785–790. doi: 10.1002/bjs.1800770722. [DOI] [PubMed] [Google Scholar]
  16. Elgin R. G., Busby W. H., Jr, Clemmons D. R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci U S A. 1987 May;84(10):3254–3258. doi: 10.1073/pnas.84.10.3254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Froesch E. R., Zapf J. Insulin-like growth factors and insulin: comparative aspects. Diabetologia. 1985 Aug;28(8):485–493. doi: 10.1007/BF00281982. [DOI] [PubMed] [Google Scholar]
  18. Guler H. P., Zapf J., Froesch E. R. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 1987 Jul 16;317(3):137–140. doi: 10.1056/NEJM198707163170303. [DOI] [PubMed] [Google Scholar]
  19. Guler H. P., Zapf J., Scheiwiller E., Froesch E. R. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4889–4893. doi: 10.1073/pnas.85.13.4889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hodgkinson S. C., Davis S. R., Burleigh B. D., Henderson H. V., Gluckman P. D. Metabolic clearance rate of insulin-like growth factor-I in fed and starved sheep. J Endocrinol. 1987 Nov;115(2):233–240. doi: 10.1677/joe.0.1150233. [DOI] [PubMed] [Google Scholar]
  21. Hodgkinson S. C., Moore L., Napier J. R., Davis S. R., Bass J. J., Gluckman P. D. Characterization of insulin-like growth factor binding proteins in ovine tissue fluids. J Endocrinol. 1989 Mar;120(3):429–438. doi: 10.1677/joe.0.1200429. [DOI] [PubMed] [Google Scholar]
  22. Jacob R., Barrett E., Plewe G., Fagin K. D., Sherwin R. S. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest. 1989 May;83(5):1717–1723. doi: 10.1172/JCI114072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. King G. L., Kahn C. R., Rechler M. M., Nissley S. P. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor. J Clin Invest. 1980 Jul;66(1):130–140. doi: 10.1172/JCI109826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Martin J. L., Baxter R. C. Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem. 1986 Jul 5;261(19):8754–8760. [PubMed] [Google Scholar]
  25. McCarthy T. L., Centrella M., Canalis E. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology. 1989 Jan;124(1):301–309. doi: 10.1210/endo-124-1-301. [DOI] [PubMed] [Google Scholar]
  26. Meuli C., Zapf J., Froesch E. R. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart. Diabetologia. 1978 Apr;14(4):255–259. doi: 10.1007/BF01219425. [DOI] [PubMed] [Google Scholar]
  27. Nissen S. L., Van Huysen C., Haymond M. W. Measurement of branched chain amino acids and branched chain alpha-ketoacids in plasma by high-performance liquid chromatography. J Chromatogr. 1982 Oct 8;232(1):170–175. doi: 10.1016/s0378-4347(00)86021-1. [DOI] [PubMed] [Google Scholar]
  28. O'Sullivan U., Gluckman P. D., Breier B. H., Woodall S., Siddiqui R. A., McCutcheon S. N. Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation. Endocrinology. 1989 Nov;125(5):2793–2794. doi: 10.1210/endo-125-5-2793. [DOI] [PubMed] [Google Scholar]
  29. Poggi C., Le Marchand-Brustel Y., Zapf J., Froesch E. R., Freychet P. Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology. 1979 Sep;105(3):723–730. doi: 10.1210/endo-105-3-723. [DOI] [PubMed] [Google Scholar]
  30. Ponting G. A., Halliday D., Teale J. D., Sim A. J. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet. 1988 Feb 27;1(8583):438–440. doi: 10.1016/s0140-6736(88)91232-9. [DOI] [PubMed] [Google Scholar]
  31. Rechler M. M., Zapf J., Nissley S. P., Froesch E. R., Moses A. C., Podskalny J. M., Schilling E. E., Humbel R. E. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology. 1980 Nov;107(5):1451–1459. doi: 10.1210/endo-107-5-1451. [DOI] [PubMed] [Google Scholar]
  32. Roeder R. A., Hossner K. L., Sasser R. G., Gunn J. M. Regulation of protein turnover by recombinant human insulin-like growth factor-I in L6 myotube cultures. Horm Metab Res. 1988 Nov;20(11):698–700. doi: 10.1055/s-2007-1010920. [DOI] [PubMed] [Google Scholar]
  33. STEELE R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci. 1959 Sep 25;82:420–430. doi: 10.1111/j.1749-6632.1959.tb44923.x. [DOI] [PubMed] [Google Scholar]
  34. Scheiwiller E., Guler H. P., Merryweather J., Scandella C., Maerki W., Zapf J., Froesch E. R. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature. 1986 Sep 11;323(6084):169–171. doi: 10.1038/323169a0. [DOI] [PubMed] [Google Scholar]
  35. Schoenle E., Zapf J., Hauri C., Steiner T., Froesch E. R. Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh) 1985 Feb;108(2):167–174. doi: 10.1530/acta.0.1080167. [DOI] [PubMed] [Google Scholar]
  36. Schoenle E., Zapf J., Humbel R. E., Froesch E. R. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 1982 Mar 18;296(5854):252–253. doi: 10.1038/296252a0. [DOI] [PubMed] [Google Scholar]
  37. Vetter U., Kupferschmid C., Lang D., Pentz S. Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro. Basic Res Cardiol. 1988 Nov-Dec;83(6):647–654. doi: 10.1007/BF01906959. [DOI] [PubMed] [Google Scholar]
  38. Wilson D. M., Perkins S. N., Thomas J. A., Seelig S., Berry S. A., Hamm T. E., Jr, Hoffman A. R., Hintz R. L., Rosenfeld R. G. Effects of elevated serum insulinlike growth factor-II on growth hormone and insulinlike growth factor-I mRNA and secretion. Metabolism. 1989 Jan;38(1):57–62. doi: 10.1016/0026-0495(89)90180-7. [DOI] [PubMed] [Google Scholar]
  39. Wolfe R. R., Shaw J. H. Glucose and FFA kinetics in sepsis: role of glucagon and sympathetic nervous system activity. Am J Physiol. 1985 Feb;248(2 Pt 1):E236–E243. doi: 10.1152/ajpendo.1985.248.2.E236. [DOI] [PubMed] [Google Scholar]
  40. Wolfe R. R. Tracers in metabolic research: radioisotope and stable isotope/mass spectrometry methods. Lab Res Methods Biol Med. 1984;9:1–287. [PubMed] [Google Scholar]
  41. Zapf J., Hauri C., Waldvogel M., Froesch E. R. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest. 1986 Jun;77(6):1768–1775. doi: 10.1172/JCI112500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zapf J., Schmid C., Froesch E. R. Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab. 1984 Mar;13(1):3–30. doi: 10.1016/s0300-595x(84)80006-7. [DOI] [PubMed] [Google Scholar]
  43. Zapf J., Schoenle E., Froesch E. R. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem. 1978 Jun 15;87(2):285–296. doi: 10.1111/j.1432-1033.1978.tb12377.x. [DOI] [PubMed] [Google Scholar]
  44. Ziegler T. R., Young L. S., Manson J. M., Wilmore D. W. Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann Surg. 1988 Jul;208(1):6–16. doi: 10.1097/00000658-198807000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES